Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-World Persistence and Effectiveness of Upadacitinib in Rheumatoid Arthritis in Kansai Region
jRCT1050260140Not yet recruiting
- Sponsor
- Osaka Metropolitan University
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of upadacitinib in rheumatoid arthritis (RA) (5 arms), sponsored by Osaka Metropolitan University. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
upadacitinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on jRCT1050260140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1050260140.